MIGUEL ANGEL
MARCHENA FERNANDEZ
Investigador en el periodo 2015-2023
Universidad Complutense de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (3)
2022
-
Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa
Cell Death and Disease, Vol. 13, Núm. 4
2018
-
Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa
Molecular Neurodegeneration, Vol. 13, Núm. 1
-
Removal of the blue component of light significantly decreases retinal damage after high intensity exposure
PLoS ONE, Vol. 13, Núm. 3